Search For "serum institute of india"
Updated : 1 day, 13 hours ago IST
New Delhi [India], October 16 (ANI): India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready,
Updated : 1 week, 3 days ago IST
New Delhi [India], October 7 (ANI): Serum Institute of India will export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh, to help them fight against the pandemic, sources said.
Updated : 2 weeks, 2 days ago IST
Pune (Maharashtra) [India], October 1 (ANI): Serum Institute of India (SII) has supplied 78 crore doses of its COVID-19 vaccine Covishield so far and its target is to supply almost 21.50 crore doses in the month of October, informed the sources to ANI on Friday.
Updated : 2 weeks, 3 days ago IST
New Delhi [India], September 30 (ANI): India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin in the month of October, said government sources.
Updated : 3 weeks, 4 days ago IST
New Delhi [India], September 22 (ANI): The United Kingdom has recognised Serum Institute of India-manufactured Covid-19 vaccine Covishield in its new travel rules but has not removed quarantine restrictions concerning Indians.
Updated : 1 month ago IST
New Delhi [India], September 17 (ANI): Hoping to strengthen India's position as a global vaccine and biologics manufacturing powerhouse, COVID-19 vaccine Covishield maker Serum Institute of India (SII) announced a strategic alliance with biopharmaceutical company Biocon Biologics Limited (BB
New Delhi [India], September 15 (ANI): Prime Minister Narendra Modi, West Bengal Chief Minister Mamata Banerjee and Serum Institute of India (SII) CEO Adar Poonawala have been listed in the Time Magazine's 100 Most Influential People of 2021.
Updated : 2 months ago IST
Pune (Maharashtra) [India], August 17 (ANI): Serum Institute of India (SII) acquired a 50 pc stake of SCHOTT Kaisha to become SCHOTT's joint venture partner and secure pharma packaging supply, Serum Institute of India announced on Tuesday.
Pune (Maharashtra) [India], August 14 (ANI): Mixing two different vaccines of COVID-19 is a very risky decision and it is must be discouraged, said Cyrus Poonawalla, chairman of Serum Institute of India (SII) on Friday.
New Delhi [India], August 13 (ANI): Serum Institute of India's chairman and managing director Cyrus Poonawalla on Friday praised the Narendra Modi government for bringing reforms in the vaccine industry for getting permissions and licences on priority and said difficulties to get licenses an
Updated : 2 months, 1 week ago IST
New Delhi [India], August 6 (ANI): In order to ramp up COVID-19 vaccine supply in the country, Union Health Minister Mansukh Mandaviya on Friday met Serum Institute of India (SII) CEO Adar Poonawalla in the national capital and held a discussion over the supply of Covishield vaccine.
New Delhi [India], August 6 (ANI): More than 136 crore COVID-19 vaccine doses are expected to be available till the end of this year, informed the Centre.